---
title: "Corbus Pharmaceuticals Holdings Inc. Stock Underperforms Tuesday When Compared To Competitors"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/296271816.md"
description: "Corbus Pharmaceuticals Holdings Inc. (CRBP) shares fell 3.91% to $10.08 on Tuesday, underperforming competitors like Vanda Pharmaceuticals and Fortress Biotech. The decline ended a five-day winning streak and occurred amid broader market weakness, with the NASDAQ Composite down 1.33%. Trading volume was below the 50-day average."
datetime: "2026-08-18T21:21:30.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/296271816.md)
  - [en](https://longbridge.com/en/news/296271816.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/296271816.md)
generator: "portal-rs"
---

# Corbus Pharmaceuticals Holdings Inc. Stock Underperforms Tuesday When Compared To Competitors

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Corbus Pharmaceuticals Holdings Inc. (CRBP) shed 3.91% to $10.08 Tuesday, on what proved to be an all-around rough trading session for the stock market, with the NASDAQ Composite Index falling 1.33% to 26,289.71 and Dow Jones Industrial Average falling 0.22% to 53,343.40.

The stock's fall snapped a five-day winning streak.

Corbus Pharmaceuticals Holdings Inc. closed 50.97% short of its 52-week high of $20.56, which the company reached on October 20th.

The stock underperformed when compared to some of its competitors Tuesday, as Vanda Pharmaceuticals Inc. (VNDA) rose 3.42% to $5.44, Fortress Biotech Inc. (FBIO) rose 3.19% to $2.91, and Viking Therapeutics Inc. (VKTX) fell 0.77% to $33.37.

Trading volume (329,116) remained 54,139 below its 50-day average volume of 383,255.

Data source: Dow Jones Market Data, FactSet. Data compiled August 18, 2026.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

(END) Dow Jones Newswires

08-18-26 1721ET

### Related Stocks

- [CRBP.US](https://longbridge.com/en/quote/CRBP.US.md)
- [.IXIC.US](https://longbridge.com/en/quote/.IXIC.US.md)
- [.DJI.US](https://longbridge.com/en/quote/.DJI.US.md)
- [VNDA.US](https://longbridge.com/en/quote/VNDA.US.md)
- [FBIO.US](https://longbridge.com/en/quote/FBIO.US.md)
- [VKTX.US](https://longbridge.com/en/quote/VKTX.US.md)
- [FBIOP.US](https://longbridge.com/en/quote/FBIOP.US.md)

## Related News & Research

- [Corbus Pharma CFO Sean Moran sells 12,000 shares for $120,971](https://longbridge.com/en/news/295447150.md)
- [Corbus Pharma CMO Nicacio Leonardo Viana files initial beneficial ownership statement](https://longbridge.com/en/news/294867785.md)
- [BUZZ-Mid-cap drugmakers face limited impact from Trump drug pricing deals, analysts say](https://longbridge.com/en/news/297637201.md)
- [Apnimed, Inc.'s Quiet Period Will End  on September 9th (NASDAQ:APMD)](https://longbridge.com/en/news/297735393.md)
- [Corbus says Phase 1b CANYON-1 obesity trial of CRB-913 reaches last patient last visit](https://longbridge.com/en/news/294824963.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**